AlphAIAlphAI — Financial news for AI agents
yahoo.comAUG 203 min read$EVGN

Evogene Ltd. Q2 2026 Earnings Call Summary

Evogene Ltd. reported a 62% year-over-year net loss improvement to $1.8M in Q2 2026, driven by reduced operating expenses. The company restructured, cutting headcount and lowering cash burn. It monetized non-core assets and upgraded its ChemPass AI platform. Management aims to transition to preclinical trials and expects revenue growth from partnerships and milestone payments. Geopolitical risks in Israel and the Middle East were highlighted. Candidate tickers: EVGN.

Original reporting
yahoo.com
Published Aug 20, 2026, 8:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 9:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Evogene Ltd. Q2 2026 Earnings Call Summary — source image
Source · yahoo.com
Decision brief

The 30-second read

$EVGNNeutralMed
01

Why it matters

The earnings release provides fresh financial metrics for a micro‑cap biotech, offering traders new data to reassess valuation.

02

Market read

First disclosure of Q2 2026 results introduces new loss and cash‑burn figures, influencing short‑term trading decisions.

03

What to watch

Potential future partnership with Bayer despite current collaboration ending.

Relevance 6/10Novelty 7/10Timing: post‑earnings today

Background

Evogene presented its Q2 2026 earnings call, detailing operational restructuring, cash burn reduction, and asset monetization.

Company-level read

Ticker impact

$EVGNNeutralMedium confidence
Context

Q2 2026 net loss narrowed to $1.8M and cash burn cut to $8.5‑9.5M, plus $15.25M asset sale to ICL.

Expected impact

Potential modest upside if market views cash preservation positively.

Evidence & confidence

Micro‑cap earnings with cost cuts are material for near‑term traders but limited scale.

Market effects

Sector

Highlights AI‑driven computational chemistry trend in pharma and ag‑chem sectors.

Regional

Geopolitical risk in Israel noted, may affect regional biotech sentiment.

Global

Limited to niche biotech investors; no broad market effect.

Counterpoint

What could challenge this read

Cost cuts may mask underlying revenue weakness; investors should stay cautious.

Key entities

  • Company
    Evogene Ltd.

    AI‑driven computational chemistry firm.

  • Company
    ICL

    Buyer of Evogene's Lavie Bio asset.

Read at source← All news

Related articles

AUG 18
$EVGNMed

Evogene Ltd. (EVGN): Financial results for Q2 2026

Evogene Ltd. (EVGN) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Evogene Reports Second Quarter and First Half 2026 Financial Results · Company continues strategic transformation, initiated in 2025, into a focused, AI-driven computational chemistry company, with significant progress across pharmaceutical and agricultural product d

SEC EDGAR 6-K2 min
OCT 23
$SAMMed

Boston Beer (SAM) Q3 2026 Earnings Call Transcript

Boston Beer (SAM) reported Q3 2026 earnings, highlighting a 90-basis-point gross margin increase to 51.7% and $80M in share repurchases. Sun Cruiser grew 60%, while Angry Orchard saw consecutive quarter growth. Full-year guidance was narrowed, with depletions and shipments expected to decline mid-single digits. The company raised gross margin and EPS guidance despite elevated freight costs.

finance.yahoo.com2 min
OCT 23
$WDCHighAI 8/10

Western Digital Delivers Better-Than-Expected Earnings, Stock Hit by After-Hours Selling

Western Digital (WDC) reported Q1 FY2027 earnings of $4.64 per share, beating expectations, with revenue up 55% YoY to $4.38B. Despite strong results, shares fell 6.43% during trading and 6% after-hours due to concerns over rising capital expenditure and financing conditions. CEO Irving Tan cited stable demand and efficient execution as growth drivers. The company raised its quarterly dividend and provided optimistic guidance for Q2.

nai500.com2 min
OCT 23
$WDCHighAI 9/10

WDC (WDC) Q1 2027 Earnings Call Transcript

WDC reported Q1 2027 revenue of $4.4B, up 55% YoY, driven by strong demand for high-capacity data storage solutions. The company shipped 248 exabytes, up 22% YoY, and expects revenue to grow to $5.1B in Q2 2027. WDC is transitioning customers to higher capacity drives and plans to begin volume shipments of its HAMR technology in early 2027. The company also increased its quarterly dividend by 17%.

finance.yahoo.com2 min
OCT 23
$DECKHighAI 8/10

Deckers (DECK) Q2 2027 Earnings Call Transcript

Deckers (DECK) reported Q2 2027 revenue growth of 3.5%, with HOKA and UGG up 7% and 4% respectively. EPS was $2.31, including a $0.28 tariff benefit, or $2.03 excluding it, exceeding guidance. The company maintained healthy margins and updated its fiscal year outlook to reflect measured growth due to economic pressures. International markets, particularly APAC, showed strength, while U.S. e-commerce faced challenges due to promotional activity.

finance.yahoo.com3 min